Brooklyn Investment Group’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Brooklyn Investment Group's BIIB Position: Q1 2026 in Review
Brooklyn Investment Group increased its Biogen (BIIB) stake by 28% in Q1 2026, buying an estimated $299K and bringing the position to 7,323 shares worth $1.34M. The position accounts for 0.04% of the portfolio, ranked #423.
Brooklyn Investment Group first reported a position in BIIB in Q3 2024 and has held it in 7 quarters since. 1,009 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.
- Brooklyn Investment Group held 7,323 shares of Biogen worth $1.34M as of Q1 2026.
- Brooklyn Investment Group bought 1,621 Biogen shares in Q1 2026, an estimated $299K.
- Biogen made up 0.04% of Brooklyn Investment Group's portfolio in Q1 2026, its #423 holding.
- Brooklyn Investment Group first reported a position in Biogen in Q3 2024 and has held it in 7 quarters since.
- 1,009 funds tracked by Wall St. Rank held Biogen as of Q1 2026.
Based on Brooklyn Investment Group's 13F filing for Q1 2026, filed 29 Apr 2026.